C4 Therapeutics (CCCC) Stock Price
$1.44 3.4%
to add to portfolio
AI Score
-
Alternative
7 -
Fundamental
2 -
Technical
3
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on C4 Therapeutics, AI stock picks, stock alerts and much more.
CCCC AI Stock Analysis
AI stock analysis for CCCC is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like C4 Therapeutics (CCCC) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
C4 Therapeutics (CCCC) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of C4 Therapeutics (CCCC), currently trading at $1.44, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About CCCC
-
C4 Therapeutics, Inc.
-
Symbol
CCCC
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
102.3M
Similar Stocks
 |
Catalyst Pharmaceuticals CPRX |
$22.81 1.8% |
6 |
 |
Inovio Pharmaceuticals INO |
$1.95 2.6% |
3 |
 |
Moderna MRNA |
$25.4 0.6% |
3 |
 |
Anavex Life Sciences AVXL |
$9.03 1.2% |
7 |
 |
BridgeBio Pharma BBIO |
$40 0.2% |
7 |
News
CCCC Alternative Data
Web Traffic
C4 Therapeutics receives an estimated 6545 monthly visitors to c4therapeutics.com.
-
Web Traffic
6545
-
Change from Previous Month
67.9%
-
3 Month Change
43.4%
-
YoY Change
43.4%
Twitter Followers
C4 Therapeutics has 1,774 Twitter Followers on its main Twitter (also known as X) account, which is up by 0.3% over the last month.
-
Twitter Followers
1774
-
Daily Change
0%
-
1 Month Change
0.3%
-
3 Month Change
2.1%
-
YoY Change
2.1%
LinkedIn Followers
16,457 are following C4 Therapeutics on LinkedIn, up by 0.7% over the last month.
-
LinkedIn Followers
16457
-
Daily Change
0%
-
1 Month Change
0.7%
-
3 Month Change
2.2%
Job Postings
C4 Therapeutics currenly has an estimated 0 open job postings.
-
Job Postings
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
100%
-
YoY Change
100%
LinkedIn Employees
According to LinkedIn, C4 Therapeutics has 126 employees, up by 1.6% over the last month.
-
LinkedIn Employees
126
-
Daily Change
0%
-
1 Month Change
1.6%
-
3 Month Change
1.6%
-
YoY Change
1.6%
Reddit Mentions
C4 Therapeutics has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Business Outlook
According to employee reviews, the business outlook among employees at C4 Therapeutics is 82 out of 100 (very bullish).
-
Business Outlook
82
-
Change from Previous Month
0%
-
3 Month Change
0%
-
YoY Change
0%
News Mentions
C4 Therapeutics was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
CCCC Financials
CCCC Key Metrics
-
Total Revenue
$5.2M
-
Net Income
-$34.6M
-
Earnings per Share
-$0.49
-
Free cash flow
-$17.9M
-
EBITDA
-$34M
-
EBITDA Ratio
-6.56017
-
Total Assets
$349.6M
CCCC 2-year Revenue & Income
CCCC 2-year Free Cash Flow
CCCC Technicals
CCCC SMA
CCCC RSI
FAQ
What's the current price of C4 Therapeutics (CCCC) Stock?
The price of an C4 Therapeutics (CCCC) share is $1.44.
What's the market cap of C4 Therapeutics?
The current market cap of C4 Therapeutics is 102.3M.
Should I buy or sell CCCC?
C4 Therapeutics shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, C4 Therapeutics is better viewed as a hold or accumulate position while waiting for further developments.
Is C4 Therapeutics a good investment?
The current analysis of C4 Therapeutics' fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in C4 Therapeutics' portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy C4 Therapeutics (CCCC) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for C4 Therapeutics stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to C4 Therapeutics (CCCC) that investors often compare it to?
C4 Therapeutics (CCCC) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.
What is the forecast for C4 Therapeutics' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast C4 Therapeutics' stock price to be around $1.47 in 2026. Starting from the current price of $1.44, this represents a 2% change in price, indicating a neutral outlook for the stock.
How to buy C4 Therapeutics (CCCC) Stock?
C4 Therapeutics stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy C4 Therapeutics shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.